Molecular epidemiology of Candida species isolated from urine at an intensive care unit

Mycoses

Volumn 48, Issue 2, 2005, Pages 126-131

  Ergon, M C ^a   Gulay Z ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Candida spp.; Epidemiology; Intensive care unit; RAPD; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CLINICAL ARTICLE; EPIDEMIOLOGICAL DATA; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; UNIVERSITY HOSPITAL; URINALYSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; EPIDEMIOLOGY, MOLECULAR; FLUCONAZOLE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TURKEY; URINE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS;

EID: 15444369170     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01086.x     Document Type: Article

References (25)

1. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
2. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997; 11: 479-96.
3. Beck-Sague CM, Jarvis WR, The National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-1990. J Infect Dis 1993; 167: 1247-51.
4. Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13: 332-70.
5. Merz WG, Roberts GD. Algorithms for detection and identification of fungi. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds), Manual of Clinical Microbiology, 7th edn. Washington, DC: ASM Press, 1999: 1167-83.
6. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Identification of fungal culture isolates. In: Color Atlas and Textbook of Diagnostic Microbiology, 5th edn. Philadelphia: Lippincott Company, 1997: 993-999.
7. Larone DH. Yeasts and yeast like organisms. In: Medically Important Fungi, 3rd edn. Washington, DC: ASM Press, 1995: 61-89.
8. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A. Wayne, Philadelphia: National Committee for Clinical Laboratory Standards, 1997.
9. Woods JP, Kersulyte D, Goldman WE, Berg DE. Fast DNA isolation from Histoplasma capsulatum: methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microbiol 1993; 31: 463-4.
10. Robert F, Lebreton F, Bougnoux ME et al. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol 1995; 33: 2366-71.
11. Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soll DR. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J Clin Microbiol 1997; 35: 2348-58.
12. Holmberg K, Feroze F. Evaluation of an optimized system for random amplified polymorphic DNA (RAPD) analysis for genotypic mapping of Candida albicans strains. J Clin Lab Anal 1996; 10: 59-69.
13. Edwards JE. Candida species. In: Mandell GL, Benett JE, Dolin R (eds), Principles and Practice of Infectious Diseases, 5th edn. Pennsylvania: Churchill Livingstone, 2000: 2656-74.
14. Stevens DA, Bennet JA. Antifungal agents. In: Mandell GL, Benett JE, Dolin R (eds), Principles and Practice of Infectious Diseases, 5th edn. Pennsylvania: Churchill Livingstone, 2000: 448-59.
15. Graybill JR. Overview of management of fungal infections: Part 2. Clin Infect Dis 1993; 17 (Suppl. 2): S513-4.
16. Rinaldi MG. Laboratory evaluation of antifungal agents: a brief overview. Clin Infect Dis 1992; 14 (Suppl. 1): S130-3.
17. Sheehan DJ, Espinel-Ingroff A, Moore LS, Webb CD. Antifungal susceptibility testing of yeasts: a brief overview. Clin Infect Dis 1993; 17 (Suppl. 2): S494-500.
18. Lehmann PF, Lin D, Lasker BA. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin Microbiol 1992; 30: 3249-54.
19. Arif S, Barkham T, Power EG, Howell SA. Techniques for investigation of an apparent outbreak of infections with Candida glabrata. J Clin Microbiol 1996; 34: 2205-9.
20. Marco F, Lockhart SR, Pfaller MA et al. Elucidating the origins of nosocomial infections with C. albicans by DNA fingerprinting with the complex probe Ca3. J Clin Microbiol 1999; 37: 2817-28.
21. Bart-Delabesse E, Van Deventer H, Goessens W et al. Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit. J Clin Microbiol 1995; 33: 3278-83.
22. Roilides E, Farmaki E, Evdoridou J et al. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 2003; 41: 735-41.
23. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002; 50: 56-65.
24. Chowdhary A, Becker K, Fegeler W et al. An outbreak of candidemia due to Candida tropicalis in a neonatal intensive care unit. Mycoses 2003; 46: 269-74.
25. Hedderwick SA, Lyons MJ, Du M, Vazquez JA, Kauffman CA. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000; 19: 663-70.